On the other hand, our results demonstrate that simultaneous presence of the rs12441817/CC (CYP1A1) and rs2070676/GG + GC (CYP2E1) genotypes confers protection against PD risk, suggesting a synergistic genetic effect from these two enzymes. The gene discussed is CYP1A1; the disease is Parkinson disease.